Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review
- 20 January 2013
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 32 (6) , 711-721
Abstract
To summarize the published evidence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) bone and joint infections. PubMed and Scopus electronic databases were searched. The annual incidence of invasive CA-MRSA infections ranged from 1.6 to 29.7 cases per 100,000, depending on the location of the population studied; bone and joint infections accounted for 2.8 to 43 % of invasive CA-MRSA infections. Surveillance studies showed that patients <2 years of age are mainly affected. Incidence rates were higher in blacks. Sixty-seven case reports and case series were identified; the majority of the patients included were children. Vancomycin and clindamycin were used effectively, in addition to surgical interventions. Seven patients out of 413 died (1.7 %) in total. Chronic osteomyelitis developed in 19 patients (data for 164 patients were available). The published evidence for CA-MRSA bone and joint infections refers mainly to children; their incidence depends on the location and race of the population. Vancomycin and clindamycin have been used effectively for their treatment.Keywords
This publication has 99 references indexed in Scilit:
- Outpatient parenteral antimicrobial therapy‐treated bone and joint infections in a tropical settingInternal Medicine Journal, 2011
- Community-Acquired MRSA Pyomyositis: Case Report and Review of the LiteratureJournal of Tropical Medicine, 2011
- Community-associated meticillin-resistant Staphylococcus aureusThe Lancet, 2010
- Community-associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006Emerging Infectious Diseases, 2009
- Septic Pulmonary Emboli and Bacteremia Associated with Deep Tissue Infections Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureusJournal of Clinical Microbiology, 2008
- Are Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Replacing Traditional Nosocomial MRSA Strains?Clinical Infectious Diseases, 2008
- Intermediate Vancomycin Susceptibility in a Community-associated MRSA CloneEmerging Infectious Diseases, 2007
- Venous thrombosis and thromboembolism in children with osteomyelitisThe Journal of Pediatrics, 2006
- Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threatThe Lancet, 2006
- Epidemiology, Treatment, and Prevention of Community-Acquired Methicillin-Resistant Staphylococcus aureus InfectionsMayo Clinic Proceedings, 2005